The vector of anti-gag p17 T cell receptor (TCR) is constructed for the engineering of T cell to target HIV-1 gag p17. The T cells are genetically modified through transduction with a lentiviral vector expressing gag p17-specific T cell receptor. And the vector product was designed for the treatment of HIV-1 infection.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-C206Z||Human anti-gag T cell receptor, pCDTCR1|
|VP-TCR-C151||Lenti-gag p17 T cell receptor (C-4) Viral Particle|
|VP-TCR-C155||Lenti-gag T cell receptor (HIV-B57-TW10) Viral Particle|
|VP-TCR-C161||Lenti-gag (CCLCLTVFL) T cell receptor Viral Particle|
|TCR-C067Z||Human anti-gag p17 (SLFNTVATL) T cell receptor (T5-004), pCDTCR1|
|VP-TCR-C150||Lenti-gag p17 T cell receptor (52H8) Viral Particle|
|TCR-C068Z||Human anti-gag p17 T cell receptor (1.9), pCDTCR1|
|VP-TCR-C159||Lenti-gag T cell receptor (HIV-B27-KK10) Viral Particle|
|TCR-L212||Human anti-gag T cell receptor (868), pCDTCR1|
|TCR-L332||Human anti-gag T cell receptor (HIV-B8-EI8), pCDTCR1|
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved